Trial Information
Feasibility of a Compassionate Same-Day Evaluation and Delivery of Single Fraction Radiotherapy for Palliation of Symptomatic Bony Metastasis in Hospice Patients
Inclusion Criteria:
- Symptomatic osseous bone lesion(s) from any malignancy, whether primary of
metastatic, with histological confirmation of malignancy.
- Currently enrolled in hospice and referred for single fraction palliative
radiotherapy.
- Performance status (to be evaluated by the radiation oncologist), Karnofsky
Performance Scale ≥ 20 or ECOG Performance Scale < 5 .
- Ability to understand and willingness to sign a written informed consent document
Exclusion Criteria:
- Pregnancy.
- Unable to understand English.
- Unable to complete forms with assistance.
- Concurrent enrollment in a study of pain management involving medications or devices.
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Feasibility of treatment delivery in the same day as initial evaluation
Outcome Description:
Patient evaluation will consist of surveys conducted at the time of treatment measured by the Radiation Oncologist Evaluation and Feasibility Assessments survey
Outcome Time Frame:
Up to 6 months
Safety Issue:
No
Principal Investigator
Drew Moghanaki, MD, MPH
Investigator Role:
Principal Investigator
Investigator Affiliation:
Virginia Commonwealth University
Authority:
United States: Institutional Review Board
Study ID:
MCC-14596
NCT ID:
NCT01760941
Start Date:
March 2013
Completion Date:
June 2015
Related Keywords:
- Symptomatic Osseous Bone Lesions From Any Malignancy
- Urology
- Prostate
- Breast
- Lung
- Chest
- Neoplasms
- Neoplasm Metastasis
Name | Location |
Virginia Commonwealth University/Massey Cancer Center |
Richmond, Virginia 23298 |